PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
0.96%
Growth of 0.96% versus flat Healthcare revenue. Walter Schloss would verify growth quality.
42.86%
Cost growth of 42.86% versus flat Healthcare costs. Walter Schloss would verify cost control.
-116.90%
Gross profit decline while Healthcare median is 0.00%. Seth Klarman would investigate competitive position.
-116.74%
Margin decline while Healthcare median is 0.00%. Seth Klarman would investigate competitive position.
-67.07%
R&D reduction while Healthcare median is 0.00%. Seth Klarman would investigate competitive implications.
-4.47%
G&A reduction while Healthcare median is 0.00%. Seth Klarman would investigate efficiency gains.
25.86%
Marketing expense change of 25.86% versus flat Healthcare spending. Walter Schloss would verify adequacy.
25.44%
Other expenses change of 25.44% versus flat Healthcare costs. Walter Schloss would verify efficiency.
9.97%
Operating expenses growth exceeding 1.5x Healthcare median of 3.85%. Jim Chanos would check for waste.
28.73%
Total costs growth exceeding 1.5x Healthcare median of 4.05%. Jim Chanos would check for waste.
646.45%
Interest expense change of 646.45% versus flat Healthcare costs. Walter Schloss would verify control.
-16.68%
D&A reduction while Healthcare median is 1.00%. Seth Klarman would investigate efficiency.
-242.73%
EBITDA decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
492.57%
Margin change of 492.57% versus flat Healthcare. Walter Schloss would verify quality.
1962.12%
Operating income growth while Healthcare declines. Peter Lynch would examine advantages.
1942.56%
Margin change of 1942.56% versus flat Healthcare. Walter Schloss would verify quality.
-89.29%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-1011.45%
Pre-tax income decline while Healthcare median is -0.67%. Seth Klarman would investigate causes.
-1002.80%
Pre-tax margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-107.81%
Tax expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-1159.97%
Net income decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-1149.92%
Net margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-1118.10%
EPS decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-1118.10%
Diluted EPS decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
4.74%
Share count reduction below 50% of Healthcare median of 0.01%. Jim Chanos would check for issues.
4.12%
Diluted share reduction below 50% of Healthcare median of 0.00%. Jim Chanos would check for issues.